
AN12855 (AN-12855) is мощный, cofactor-independent M. tuberculosis InhA ингибитор, binds to and inhibits InhA с IC50 of 0.03 uM, shows мощный activity against whole-клетка M. tuberculosis H37Rv with IC90 of 0.09 uM; AN12855 demonstrates мощный activity against препарат-susceptible and препарат-resistant strains of M. tuberculosis, exhibits comparable efficacy to the frontline antitubercular препарат isoniazid (INH) in both acute and chronic models of TB infection with a lower potential for resistance development and shows in vitro activity against conventional KatG-mediated INH-resistant M. tuberculosis.
AN12855 (AN-12855) is potent, cofactor-independent M. tuberculosis InhA inhibitor, binds to and inhibits InhA with IC50 of 0.03 uM, shows potent activity against whole-cell M. tuberculosis H37Rv with IC90 of 0.09 uM; AN12855 demonstrates potent activity against drug-susceptible and drug-resistant strains of M. tuberculosis, exhibits comparable efficacy to the frontline antitubercular drug isoniazid (INH) in both acute and chronic models of TB infection with a lower potential for resistance development and shows in vitro activity against conventional KatG-mediated INH-resistant M. tuberculosis.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.